Dasatinib and Quercetin Mitigate Age‐Related Alveolar Bone Inflammaging and Neutrophil Infiltration
Oral Diseases · 2025
DOI: 10.1111/odi.15291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Jinru Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: Dasatinib, Alveolar Bone Loss, Quercetin, Neutrophil Infiltration. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, International Orthodontics Foundation Young Research Grant.
Abstract (Originalsprache)
Objective
Age‐related alveolar bone resorption poses a major dental health challenge, yet its mechanisms and treatments are poorly understood. This study investigates the impact of dasatinib and quercetin (D + Q) treatment on senescent cells (SnCs), senescence‐associated secretory phenotype (SASP), and neutrophil infiltration in aged alveolar bone, aiming to develop new strategies for combating age‐related bone resorption.
Methods
C57BL/6 mice (2 and 18 months) were used to examine alveolar bone resorption, inflammaging, and neutrophil infiltration. Aged mice received D + Q treatment to assess therapeutic effects. Key measurements included cementoenamel junction to the alveolar bone crest (CEJ‐ABC) distance, periodontal ligament (PDL) thickness, osteometabolism markers, SnCs accumulation, SASP expression, and neutrophil infiltration.
Results
Aged alveolar bone showed increased CEJ‐ABC distance, atrophied periodontal ligament, and unbalanced osteometabolism, along with elevated SnCs, SASP, and neutrophils compared to young controls. D + Q treatment improved these conditions by reducing CEJ‐ABC distance, enhancing periodontal ligament health, and boosting bone metabolism. It also lowered the expression of SnCs, SASP, and neutrophil markers.
Conclusion
D + Q treatment effectively mitigates alveolar bone aging by clearing SnCs, lowering SASP levels, and reducing neutrophil aggregation, presenting a novel approach for age‐related bone resorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
- Hospital of Stomatology, Zunyi Medical University, Zunyi, China.
- Department of Physiology, Tokyo Dental College, Tokyo, Japan.
- Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
ORCID-Profile: Jinru Tang, Longjiang Li, Bo Li
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- International Orthodontics Foundation Young Research Grant
- Research and Development Program from West China Hospital of Stomatology, Sichuan University
- China Postdoctoral Science Foundation
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Tang, J., Li, J., Hou, Z., He, R., Li, B., Gong, J., Xie, Y., Meng, W., Liu, Y., Ouchi, T., Li, L., & Li, B. (2025). Dasatinib and Quercetin Mitigate Age‐Related Alveolar Bone Inflammaging and Neutrophil Infiltration. Oral Diseases. https://doi.org/10.1111/odi.15291
Vancouver
Tang J, Li J, Hou Z, He R, Li B, Gong J, et al. Dasatinib and Quercetin Mitigate Age‐Related Alveolar Bone Inflammaging and Neutrophil Infiltration. Oral Diseases. 2025. doi:10.1111/odi.15291
BibTeX
@article{Tang2025,
author = {Tang, Jinru and Li, Jingya and Hou, Zeyu and He, Rong and Li, Bingzhi and Gong, Jiajing and Xie, Yuhang and Meng, Wanrong and Liu, Yunkun and Ouchi, Takehito and Li, Longjiang and Li, Bo},
title = {Dasatinib and Quercetin Mitigate Age‐Related Alveolar Bone Inflammaging and Neutrophil Infiltration},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15291}
}
EUVIMED